Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer

Experimental and Therapeutic Medicine

Volumn 1, Issue 1, 2010, Pages 153-160

  Fernando, Herman ^a   Martin, Tracey A ^a   Douglas Jones, Anthony ^a   Kynaston, Howard G ^a   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Cell adhesion; Cytoskeletal proteins; ERM family; Ezrin; Metastasis; Moesin; Radixin; Survival

Indexed keywords

BETA ACTIN; EZRIN; MESSENGER RNA; MOESIN; RADIXIN;

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; METASTASIS; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 77951743338     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000025     Document Type: Article

References (25)

1. Sato N, Funayama N, Nagafuchi A, Yonemura S and Tsukita S: A gene family consisting of ezrin, radixin and moesin. Its specifc localization at actin flament/plasma membrane association sites. J Cell Sci 103: 131-143, 1992.
2. Pataky F, PironkovA R and Hudspeth AJ: Radixin is a constituent of stereocilia in hair cells. Proc Natl Acad Sci USA 101: 2601-2606, 2004.
3. Faure S, Salazar-Fontana LI, Semichon M, Tybulewicz VL, Bismuth G, Trautmann A, Germain RN and Delon J: Erm proteins regulate cytoskeleton relaxation promoting t cell-apc conjugation. Nat Immunol 5: 272-279, 2004.
4. Vaheri A, Carpén O, Heiska L, Helander TS, Jääskeläinen J, Majander-nordenswan P, Sainio M, Timonen t and Turunen O: The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr Opin Cell Biol 9: 659-666, 1997.
5. Hiscox S and Jiang WG: Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/β-catenin. J Cell Sci 112: 3081-3090, 1999.
6. Mhawech-Fauceglia P, Dulguerov P, Beck A, Bonet M and Allal AS: Value of ezrin, maspin and nm23-h1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. J Clin Pathol 60: 185-189, 2007.
7. Valdman A, Fang X, Pang ST, Nilsson B, Ekman P and Egevad L: Ezrin expression in prostate cancer and benign prostatic tissue. Eur Urol 48: 852-857, 2005.
8. Weng WH, Ahlen J, Astrom K, Lui WO and Larsson C: Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11: 6198-6204, 2005.
9. Bruce B, Khanna G, Ren L, Landberg G, Jirstrom K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P, Baird K, Mcclatchey A, Bretscher A, Hewitt SM and Khanna C: Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 24: 69-78, 2007.
10. Hanavadi S, Martin T, Mansel R and Jiang WG: Interleukin-11 and its receptor expression in human breast cancer. Ann Surg Oncol 13: 802-808, 2006.
11. Martin T, Goyal A, Mansel R, Watkins G and Jiang W: The transcription factor for the E-cadherin complex, twist, slug and snail, in human breast cancer. Ann Surg Oncol 12: 1-9, 2005.
12. Jiang WG, Watkins G, Lane J, Cunnick G, Douglas-Jones A, Mokbel K and Mansel R: Prognostic value of rho family and rho-gdis in breast cancer. Clin Cancer Res 9: 6432-6440, 2003.
13. Jiang WG, Douglas-Jones A and Mansel R: Level of expression of ppar-gamma and its co-activator (ppar-gca) in human breast cancer. Int J Cancer 106: 752-757, 2003.
14. Nazarenko A, Bhatnagar S and Hohman R: A closed tube format for amplifcation and detection of DNA based on energy transfer. Nucleic Acids Res 25: 2516-2521, 1997.
15. Parr C, Watkins G and Jiang WG: The possible correlation of notch-1 and notch-2 with clinical outcome and tumor clinico-pathological parameters in human breast cancer. Int J Mol Med 14: 779-786, 2004.
16. Jiang WG, Grimshaw D, Lane J, Martin T, Abounader R, Laterra J and Mansel RE: A hammerhead ribozyme suppresses expresion of hepatocyte growth factor/scatter factor receptor c-mEt and reduces migration and invasiveness of breast cancer cells. Clin Cancer Res 7: 2555-2562, 2001.
17. Ye L, Martin T, Parr C, Harrison G, Mansel R and Jiang WG: Biphasic effects of 17-β-oestradiol on expression of occludin and transendothelial resistance and paracellular permiability in human vascular endothelial cells. J Cell Physiol 196: 362-369, 2003.
18. King J, Ofori-acquah SF, Stevens T, Al-Mehdi A-B, Fodstad O and Jiang WG: Activated leukocyte adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6: 478-487, 2004.
19. Davies G, Jiang WG and Mason MD: Cell-cell adhesion and signalling intermediates in human prostate Cancer. J Urol 163: 985-992, 2000.
20. Berryman M, Franck Z and Bretscher A: Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial Cells. J Cell Sci 105: 1025-1043, 1993.
21. Tsukita S and Hieda Y: A new 82-kd barbed end-capping protein (radixin) localized in the cell-to-cell adherens junction: Purifca-tion and characterization. J Cell Biol 108: 2369-2382, 1989.
22. Yonemura S and Tsukita S: Direct involvement of ezrin/radixin/ moesin (Erm)-binding membrane proteins in the organization of microvilli in collaboration with activated Erm proteins. J Cell Biol 145: 1497-1509, 1999.
23. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S and Tsukita S: Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to Erm family members. J Cell Biol 125: 1371-1384, 1994.
24. Yu Y, Davicioni E, Triche TJ and Merlino G: The homeo-protein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res 66: 1982-1989, 2006.
25. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186, 2004.